TY  - JOUR
AU  - Guerrero, Marta
AU  - Ferrin, Gustavo
AU  - Rodriguez-Peralvarez, Manuel
AU  - Gonzalez-Rubio, Sandra
AU  - Sanchez-Frias, Marina
AU  - Amado, Viíctor
AU  - Pozo, Juan C
AU  - Poyato, Antonio
AU  - Ciria, Ruben
AU  - Ayllon, Maria D
AU  - Barrera, Pilar
AU  - Montero, Jose L
AU  - de la Mata, Manuel
PY  - 2019
DO  - 10.3390/ijms20020336
UR  - http://hdl.handle.net/10668/13429
T2  - International journal of molecular sciences
AB  - (1) Background: The mammalian target of rapamycin (mTOR) pathway activation is critical for hepatocellular carcinoma (HCC) progression. We aimed to evaluate the mTOR tissue expression in liver transplant (LT) patients and to analyse its influence on...
LA  - en
PB  - MDPI
KW  - Hepatocellular carcinoma
KW  - Immunosuppression
KW  - Liver transplantation
KW  - mTOR
KW  - Carcinoma, hepatocellular
KW  - Female
KW  - Humans
KW  - Kaplan-Meier estimate
KW  - Liver neoplasms
KW  - Liver transplantation
KW  - Male
KW  - Middle aged
KW  - Multivariate analysis
KW  - Neoplasm recurrence, local
KW  - Phosphorylation
KW  - Proportional hazards models
KW  - ROC curve
KW  - Signal transduction
KW  - TOR serine-threonine kinases
TI  - mTOR Expression in Liver Transplant Candidates with Hepatocellular Carcinoma: Impact on Histological Features and Tumour Recurrence.
TY  - research article
VL  - 20
ER  -